Delivery Order SPE2DB22D2211-SPE2DB23FNRD5
Award Date 7/3/23
Potential Completion Date 7/5/23
Potential Value $375
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,173.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562355585 CRYSELLE-28 TABLET 28S. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from September 29, 2023 through October 2, 2023. As the prime contractor, Amerisourcebergen will be...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifty-four thousand eight dollars to Amerisourcebergen Drug Corporation for pharmaceutical item 4561636272, described as CRYSELLE-28 TABLET 28S. The order was placed under an existing Prime Vendor contract vehicle and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by July 31, 2023 to support DLA missions. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $1,849 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561727388 CRYSELLE-28 TABLET 28S. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a one-day period of performance from August 7 to August 8, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform the contract from its location in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order valued at $2,741.91 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cryselle-28 tablets. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,846.41 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Cryselle-28 is an oral contraceptive...
- The Defense Logistics Agency awarded a delivery order valued at $1,941.91 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical...
- The Defense Logistics Agency (DLA) awarded a $2,624.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cryselle-28 tablets (28-count packages) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded contract, with no set-aside designation, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $7,221.73 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on April 22, 2025, with an ultimate completion date of April 23, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.41 Firm Fixed Price Delivery Order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cryselle-28 tablets (a contraceptive medication) under a firm fixed-price contract structure. The award, valued at $1,643.68, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an approximately $1 billion prime vendor agreement running through December 2026. The delivery order carries no...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB23FNRD5Delivery Order
The Defense Logistics Agency awarded a $375,250 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561401252, described as CRYSELLE-28 TABLET 28S. Performance will take place in Conshohocken, Pennsylvania under a schedule contract vehicle from July 3 to July 5, 2023. As a leading provider of medical supplies to the Department of Defense, Amerisourcebergen will deliver the specified medication to the customer agency. No subcontractors or set aside designations were indicated. The brief period of performance suggests an urgent requirement to supplement medical stocks in support of DLA's mission to provide logistics support to the Armed Forces.
Generated 12/20/23, 12:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $375 | 7/3/23 |